Avricore Health Inc Total Assets

Latest as of March 2026: CA$584.37K CAD ≈ $422.72K USD

Avricore Health Inc total assets. Based on the latest financial reports, Avricore Health Inc (AVCR) holds total assets worth CA$584.37K CAD (≈ $422.72K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Avricore Health Inc stock valuation for the company's overall valuation and market capitalisation.

Total Assets of Avricore Health Inc (2000–2025)

Total assets of Avricore Health Inc from 2000 to 2025. This chart illustrates how Avricore Health Inc's total assets have evolved over time, based on quarterly financial data. See Avricore Health Inc stock price for real-time trading data and today's change.

Avricore Health Inc - Asset Composition Analysis

Avricore Health Inc Total Assets Breakdown (December 2025)

Avricore Health Inc total assets breakdown as of December 2025. Avricore Health Inc's total assets of CA$584.37K consist of 65.1% current assets and 35.0% non-current assets.

Asset Category Amount (CAD) % of Total Assets
Cash & Equivalents CA$0.00 40.5%
Accounts Receivable CA$11.88K 2.1%
Inventory CA$0.00 0.0%
Property, Plant & Equipment CA$0.00 0.0%
Intangible Assets CA$3.00 0.0%
Goodwill CA$0.00 0.0%

Asset Composition Trend (2000–2025)

This chart illustrates how Avricore Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Avricore Health Inc (AVCR) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Avricore Health Inc's current assets represent 65.1% of total assets in 2025, an increase from 64.4% in 2000.
  • Cash Position: Cash and equivalents constituted 40.5% of total assets in 2025, down from 62.0% in 2000.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
  • Asset Diversification: The largest asset category is accounts receivable at 2.1% of total assets.

Avricore Health Inc Competitors by Total Assets

Key competitors of Avricore Health Inc based on total assets are shown below.

Company Country Total Assets
Revvity Inc.
NYSE:RVTY
USA $12.00 Billion
Sonic Healthcare Ltd
AU:SHL
Australia AU$16.78 Billion
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
INOVIQ LTD.
F:EGQ0
Germany €21.71 Million
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Healius Ltd
AU:HLS
Australia AU$1.77 Billion
Monash Ivf Group Ltd
AU:MVF
Australia AU$512.35 Million

Avricore Health Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.03 7.40 13.53
Quick Ratio 0.93 7.38 13.53
Cash Ratio 0.00 0.00 0.00
Working Capital CA$11.57K CA$1.20 Million CA$2.30 Million

Avricore Health Inc - Advanced Valuation Insights

This section examines the relationship between Avricore Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 35.61
Latest Market Cap to Assets Ratio 8.12
Asset Growth Rate (YoY) -75.5%
Total Assets CA$563.12K
Market Capitalization $4.57 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Avricore Health Inc's assets at a significant premium (8.12x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Avricore Health Inc's assets decreased by 75.5% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Avricore Health Inc (2000–2025)

The table below shows the annual total assets of Avricore Health Inc from 2000 to 2025.

Year Total Assets Change
2025-12-31 CA$563.12K
≈ $407.36K
-75.50%
2024-12-31 CA$2.30 Million
≈ $1.66 Million
-9.44%
2023-12-31 CA$2.54 Million
≈ $1.84 Million
-1.20%
2022-12-31 CA$2.57 Million
≈ $1.86 Million
+12.61%
2021-12-31 CA$2.28 Million
≈ $1.65 Million
+418.39%
2020-12-31 CA$440.09K
≈ $318.35K
+111.18%
2019-12-31 CA$208.40K
≈ $150.75K
-82.64%
2018-12-31 CA$1.20 Million
≈ $868.21K
-58.62%
2017-12-31 CA$2.90 Million
≈ $2.10 Million
+27.46%
2016-12-31 CA$2.28 Million
≈ $1.65 Million
-34.86%
2015-12-31 CA$3.49 Million
≈ $2.53 Million
-1.34%
2014-12-31 CA$3.54 Million
≈ $2.56 Million
+331.56%
2013-12-31 CA$820.42K
≈ $593.48K
+2.43%
2012-12-31 CA$800.99K
≈ $579.42K
+3955.45%
2011-12-31 CA$19.75K
≈ $14.29K
-89.63%
2010-12-31 CA$190.49K
≈ $137.80K
-85.92%
2009-12-31 CA$1.35 Million
≈ $978.79K
-24.07%
2008-12-31 CA$1.78 Million
≈ $1.29 Million
-29.67%
2007-12-31 CA$2.53 Million
≈ $1.83 Million
+196.66%
2006-12-31 CA$854.17K
≈ $617.89K
+293.86%
2005-12-31 CA$216.87K
≈ $156.88K
-27.92%
2004-12-31 CA$300.89K
≈ $217.66K
-63.78%
2003-12-31 CA$830.76K
≈ $600.96K
+189.93%
2002-12-31 CA$286.54K
≈ $207.28K
+50.99%
2001-12-31 CA$189.77K
≈ $137.28K
+125.97%
2000-12-31 CA$83.98K
≈ $60.75K
--

About Avricore Health Inc

V:AVCR Canada Diagnostics & Research
Market Cap
$4.57 Million
CA$6.32 Million CAD
Market Cap Rank
#28705 Global
#1264 in Canada
Share Price
CA$0.05
Change (1 day)
+0.00%
52-Week Range
CA$0.05 - CA$0.09
All Time High
CA$8.32
About

Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to A… Read more